# Clinical trials recruiting in Arkansas: 700 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 700 trials recruiting or not yet recruiting with a site in Arkansas, as read on November 19, 2026.

## The full list

Clinical trials recruiting in Arkansas: 700 rows for $35, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 12 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/state/arkansas

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 700
- Recruiting or not yet: 700
- Read on: November 19, 2026

## Trials

The 25 newest of 700, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 16, 2026 | NCT07937865 | Early Intervention for Postpartum PTSD: Comparing Written Exposure and Capnometry-Guided Breathing Therapy - Phase 2 | Stanford University | Not applicable | Not yet recruiting | Written Exposure Therapy, Breathing Techniques, PTSD (Childbirth-Related), Postpartum Care | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07937865) |
| November 4, 2026 | NCT07916480 | Roflumilast Cream 0.3% for Moderate to Severe Atopic Dermatitis | Arcutis Biotherapeutics, Inc. | Phase 3 | Recruiting | Atopic Dermatitis, Atopic Dermatitis (AD), Atopic Dermatitis (Eczema) | 415 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07916480) |
| November 2, 2026 | NCT07911124 | Ticagrelor for Inflammation and Cardiovascular Risk in Patients With Chronic Kidney Disease | University of Arkansas | Phase 2 | Recruiting | Chronic Kidney Disease (CKD) | 230 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07911124) |
| November 2, 2026 | NCT07908680 | A Study to Assess the Safety, Tolerability and Pharmacokinetics of XEP527 in Patients With Stable Schizophrenia | Novartis Pharmaceuticals | Phase 1 | Recruiting | Schizophrenia | 36 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07908680) |
| October 30, 2026 | NCT07907783 | Phase 2 Efficacy and Safety of PP405 in Adult Females With Androgenetic Alopecia | Pelage Pharmaceuticals, Inc. | Phase 2 | Recruiting | Androgenetic Alopecia | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07907783) |
| October 27, 2026 | NCT07897721 | A Study to Learn About the Study Medicine Called PF-08165784 in People With PIK3CA-Mutated Advanced or Metastatic Solid Tumors | Pfizer | Phase 1 | Not yet recruiting | Advanced Breast Cancer, Advanced or Metastatic Breast Cancer, Metastatic Breast Cancer (HR+/ HER2-), Metastatic... | 268 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07897721) |
| October 20, 2026 | NCT07881887 | A Study of LY4167586 in Participants With Obesity or Overweight With or Without Type 2 Diabetes | Eli Lilly and Company | Phase 1 | Recruiting | Obesity, Overweight, Diabetes Mellitus, Type 2 | 617 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07881887) |
| October 7, 2026 | NCT07863193 | Phase 3 Study of Denifanstat in Participants With Moderate to Severe Acne (AURORA) | Sagimet Biosciences Inc. | Phase 3 | Recruiting | Acne Vulgaris | 800 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07863193) |
| October 5, 2026 | NCT07857057 | Food Introduction for Risk Reduction, Support Tolerance: Behavioral Intervention for Toddler Eating Success | University of Texas Southwestern Medical Center | Not applicable | Not yet recruiting | Food Allergy, Early Allergen Introduction | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07857057) |
| September 29, 2026 | NCT07848191 | Rezdiffra® With Concomitant Therapies Commonly Used to Treat Comorbidities in Adults With MASH and F2-F3 Fibrosis | Madrigal Pharmaceuticals, Inc. | Phase 4 | Recruiting | MASH - Metabolic Dysfunction-Associated Steatohepatitis | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07848191) |
| September 28, 2026 | NCT07843329 | A Trial to See if Daridorexant Can Help Adults and Elderly People With Insomnia Sleep Better During the Night and Function Better During... | Idorsia Pharmaceuticals Ltd. | Phase 3 | Recruiting | Insomia Disorder | 344 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07843329) |
| September 25, 2026 | NCT07842367 | Inflammation and Medical Provider Attitudes, Cognition, and Treatment Decisions Study | University of Arkansas, Fayetteville | Phase 2 | Recruiting | Decision-Making, Patient Care, Treatment Decisions | 210 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07842367) |
| September 16, 2026 | NCT07823608 | A Study to Learn About the Monthly Dosing Study Medicine Called Berobenatide in Adults With Breathing Problems During Sleep and Overweight... | Pfizer | Phase 3 | Recruiting | Apnea, Sleep Disorders, Overweight and/or Obesity | 258 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07823608) |
| September 15, 2026 | NCT07819435 | Phase 2/3 Efficacy and Safety of PP405 in Adult Males | Pelage Pharmaceuticals, Inc. | Phase 2/3 | Recruiting | Androgenetic Alopecia | 600 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07819435) |
| September 11, 2026 | NCT07816367 | A Study to Assess the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine | TriGemX Bio, Inc. | Phase 3 | Recruiting | Migraine | 1,500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07816367) |
| September 4, 2026 | NCT07805707 | A Study on the Efficacy of a Vaccine Against Influenza in Adults ≥65 Years of Age | GlaxoSmithKline | Phase 3 | Recruiting | Influenza, Human | 54,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07805707) |
| September 3, 2026 | NCT07803250 | Impact of BPC-157 on Recovery Following Rotator Cuff Repair Surgery | University of Arkansas | Phase 1 | Not yet recruiting | Rotator Cuff Tear | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07803250) |
| September 3, 2026 | NCT07802262 | Prenatal Exercise and Glucose Regulation | University of Central Arkansas | Not applicable | Recruiting | Gestational Diabetes Mellitus, Gestational Diabetes Mellitus in Pregnancy, Insulin Resistance | 23 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07802262) |
| August 31, 2026 | NCT07795814 | A Study of EDG-15400 in Adults With Heart Failure With Preserved Ejection Fraction (EQUINOX-HFpEF) | Edgewise Therapeutics, Inc. | Phase 2 | Recruiting | Heart Failure With Preserved Ejection Fraction | 90 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07795814) |
| August 31, 2026 | NCT07795164 | Phase 3 Study of the Efficacy, Safety, and Clinical Outcomes of Pemvidutide in MASH | Altimmune, Inc. | Phase 3 | Recruiting | Metabolic Dysfunction-Associated Steatohepatitis (MASH) | 1,800 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07795164) |
| August 26, 2026 | NCT07787585 | Discontinuation of Low-Dose Levothyroxine in Older Adults With Subclinical Hypothyroidism | Sponsor not shown (see the record) | Phase 4 | Not yet recruiting | Hypothyroidism | 138 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07787585) |
| August 25, 2026 | NCT07784270 | A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight | AstraZeneca | Phase 3 | Recruiting | Obesity or Overweight, Diabetes Mellitus, Type 2 | 1,500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07784270) |
| August 24, 2026 | NCT07783425 | A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to Severe Eczema | Pfizer | Phase 3 | Recruiting | Atopic Dermatitis | 1,375 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07783425) |
| August 21, 2026 | NCT07779213 | Detection of Atrial Fibrillation Using PPG From Smartphone Cameras | Happitech BV | Observational | Recruiting | Atrial Fibrillation (AF) | 554 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07779213) |
| August 20, 2026 | NCT07775495 | Observational Study of Decentralized Urine Optical Interaction Patterns Associated With Environmental Microplastic and Nanoplastic Exposure | Ecotera Health LLC | Observational | Recruiting | Healthy Adult Participants | 15 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07775495) |

## Sites with the most of these trials

Sites as the records name them, organizations only.

| Site | City | Trials |
| --- | --- | --- |
| University of Arkansas for Medical Sciences | Little Rock | 114 |
| Arkansas Children's Hospital | Little Rock | 84 |
| Highlands Oncology Group | Fayetteville | 47 |
| Mercy Hospital Fort Smith | Fort Smith | 45 |
| NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro | Jonesboro | 34 |
| CARTI Cancer Center | Little Rock | 30 |
| CHI Saint Vincent Cancer Center Hot Springs | Hot Springs | 17 |
| Highlands Oncology Group - Fayetteville | Fayetteville | 16 |
| Highlands Oncology Group - Rogers | Rogers | 16 |
| University of Arkansas | Little Rock | 15 |
| Arrhythmia Research Group | Jonesboro | 11 |
| Applied Research Center of Arkansas | Little Rock | 10 |
| Genesis Cancer and Blood Institute | Hot Springs | 9 |
| Highlands Oncology Group, PA | Fayetteville | 9 |
| Woodland International Research Group | Little Rock | 9 |
| Arkansas Children's Research Institute | Rogers | 7 |
| Pillar Clinical Research- Little Rock | Little Rock | 7 |
| St. Bernards Medical Center | Jonesboro | 6 |
| Burke Pharmaceutical Research | Hot Springs | 5 |
| Arkansas Children's Nutrition Center | Little Rock | 5 |
| Arkansas Research Trials | North Little Rock | 5 |
| Arkansas Children's | Little Rock | 5 |
| St. Bernard's Medical Center | Jonesboro | 5 |
| Preferred Research Partners, Inc. | Little Rock | 5 |
| Arkansas Heart Hospital | Little Rock | 5 |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 1 | 30 |
| Phase 1/2 | 26 |
| Phase 2 | 131 |
| Phase 2/3 | 24 |
| Phase 3 | 265 |
| Phase 4 | 20 |
| Not applicable | 113 |
| Observational | 91 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Carcinoma, Non-Small-Cell Lung | 36 |
| Neoplasms | 24 |
| Schizophrenia | 21 |
| Breast Neoplasms | 20 |
| Lung Neoplasms | 19 |
| Atrial Fibrillation | 18 |
| Urinary Bladder Neoplasms | 18 |
| Colorectal Neoplasms | 15 |
| Neoplasm Metastasis | 15 |
| Obesity | 15 |
| Depressive Disorder, Major | 15 |
| Endometrial Neoplasms | 14 |
| Prostatic Neoplasms | 14 |
| Melanoma | 13 |
| Diabetes Mellitus, Type 2 | 13 |
| Heart Failure | 13 |
| Squamous Cell Carcinoma of Head and Neck | 12 |
| Leukemia, Myeloid, Acute | 12 |
| Ovarian Neoplasms | 12 |
| Pancreatic Neoplasms | 11 |
| Carcinoma | 10 |
| Depression | 10 |
| Multiple Myeloma | 10 |
| Dermatitis, Atopic | 9 |
| Overweight | 9 |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| National Cancer Institute (NCI) | 37 |
| University of Arkansas | 30 |
| [AstraZeneca](https://specstream.ai/data/clinical-trials/company/astrazeneca) | 24 |
| SWOG Cancer Research Network | 22 |
| [Pfizer](https://specstream.ai/data/clinical-trials/company/pfizer) | 21 |
| Children's Oncology Group | 20 |
| Arkansas Children's Hospital Research Institute | 17 |
| NRG Oncology | 16 |
| Alliance for Clinical Trials in Oncology | 16 |
| [AbbVie](https://specstream.ai/data/clinical-trials/company/abbvie) | 15 |
| [Bristol-Myers Squibb](https://specstream.ai/data/clinical-trials/company/bristol-myers-squibb) | 13 |
| [Novartis Pharmaceuticals](https://specstream.ai/data/clinical-trials/company/novartis-pharmaceuticals) | 12 |
| [Eli Lilly and Company](https://specstream.ai/data/clinical-trials/company/eli-lilly-and-company) | 12 |
| [Janssen Research & Development, LLC](https://specstream.ai/data/clinical-trials/company/janssen-research-and-development-llc) | 11 |
| [Neurocrine Biosciences](https://specstream.ai/data/clinical-trials/company/neurocrine-biosciences) | 9 |
| [GlaxoSmithKline](https://specstream.ai/data/clinical-trials/company/glaxosmithkline) | 9 |
| [Regeneron Pharmaceuticals](https://specstream.ai/data/clinical-trials/company/regeneron-pharmaceuticals) | 8 |
| ECOG-ACRIN Cancer Research Group | 7 |
| [Amgen](https://specstream.ai/data/clinical-trials/company/amgen) | 6 |
| VA Office of Research and Development | 6 |
| [Takeda](https://specstream.ai/data/clinical-trials/company/takeda) | 6 |
| University of Arkansas, Fayetteville | 6 |
| [Merck Sharp & Dohme LLC](https://specstream.ai/data/clinical-trials/company/merck-sharp-and-dohme-llc) | 6 |
| [Axsome Therapeutics, Inc.](https://specstream.ai/data/clinical-trials/company/axsome-therapeutics-inc) | 5 |
| Duke University | 5 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in Arkansas

- [Orthopedics practices in Arkansas, United States](https://specstream.ai/data/businesses/orthopedics-practices/arkansas-united-states)
- [Surgery practices in Arkansas, United States](https://specstream.ai/data/businesses/surgery-practices/arkansas-united-states)
- [Bakeries in Arkansas, United States](https://specstream.ai/data/businesses/bakeries/arkansas-united-states)
- [Distribution companies in Arkansas, United States](https://specstream.ai/data/businesses/distribution-companies/arkansas-united-states)
- [IT service companies in Arkansas, United States](https://specstream.ai/data/businesses/it-service-companies/arkansas-united-states)
- [Plastic and reconstructive surgery practices in Arkansas, United States](https://specstream.ai/data/businesses/plastic-and-reconstructive-surgery-practices/arkansas-united-states)
